(NASDAQ: WVE) Wave Life Sciences's forecast annual revenue growth rate of 3.09% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 101.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.34%.
Wave Life Sciences's revenue in 2025 is $109,230,000.On average, 17 Wall Street analysts forecast WVE's revenue for 2025 to be $7,926,255,561, with the lowest WVE revenue forecast at $2,932,702,855, and the highest WVE revenue forecast at $14,920,974,222. On average, 17 Wall Street analysts forecast WVE's revenue for 2026 to be $8,420,946,460, with the lowest WVE revenue forecast at $0, and the highest WVE revenue forecast at $17,729,628,193.
In 2027, WVE is forecast to generate $22,524,401,758 in revenue, with the lowest revenue forecast at $5,406,658,895 and the highest revenue forecast at $67,232,154,436.